SLE‐associated myelitis successfully treated by rituximab

Systemic lupus erythematosus (SLE) is an autoimmune disease. Transverse myelitis (TM) is one of the rare neurological manifestations of SLE. Here, we present a case of SLE in which TM precede other symptoms and successfully treated by Rituximab. SLE‐associated myelitis needs more attention from the...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical case reports 2022-11, Vol.10 (11), p.e6622-n/a
Hauptverfasser:	Khabbazi, Alireza, Ghadakchi, Leyla, Yazdani, Yalda, Habibzade, Elham, Mehrtabar, Saba, Khalaji, Amirreza
Format:	Artikel
Sprache:	eng
Schlagworte:	Case Report Case reports Consent Dehydrogenases Fecal incontinence Glycoproteins Hormone replacement therapy Immunotherapy Inflammatory diseases Laboratories Lupus Magnetic resonance imaging Monoclonal antibodies Patients Proteins Pulmonary arteries rituximab Spinal cord systemic lupus erythematosus Thrombosis transverse myelitis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Systemic lupus erythematosus (SLE) is an autoimmune disease. Transverse myelitis (TM) is one of the rare neurological manifestations of SLE. Here, we present a case of SLE in which TM precede other symptoms and successfully treated by Rituximab. SLE‐associated myelitis needs more attention from the medical staff to this sign can lead to faster diagnosis and timely treatment of patients.
ISSN:	2050-0904 2050-0904
DOI:	10.1002/ccr3.6622